Skip to main content
SpringerLink
Log in
Book cover

Antimicrobial Drug Resistance pp 1161–1170Cite as

Drug Resistance Assays for Mycobacterium tuberculosis

  • Chapter

Part of the book series: Infectious Disease ((ID))

The introduction of antimicrobial therapy of tuberculosis during the second half of the last century was a turning point in the millennium-old history of this disease. However, the problem of drug resistance emerged, and with it, two levels of concern. First, such resistance not only poses a public health threat to successful control of TB epidemics, but it also complicates the approach to treatment of individual patients. In previous reviews we have addressed the history of research and evolution of views based on these studies regarding the usefulness of drug susceptibility testing (1, 2). Historically, most skepticism regarding the need for drug susceptibility testing was related to the period before introduction of rifampin (RMP) and pyrazinamide (PZA). It often referred to the inability of laboratories to provide test results rapidly enough for the information to be used to adjust treatment regimens in a timely manner. In 1990, the American Thoracic Society (ATS) and the CDC published the following statement, “Given the low prevalence of drug-resistant Mycobacterium tuberculosis (MTBC) in most parts of the United States, the cost of routine testing of all initial isolates is diffi cult to justify” (3).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heifets, L. (1991) Drug susceptibility tests in the management of chemotherapy of tuberculosis, in: Drug Susceptibility in the Chemotherapy of Mycobacterial Infections (Heifets, L.B., ed.), CRC Press, Boca Raton, FL, pp. 89–121.

    Google Scholar 

  2. Heifets, L.B., Cangelosi, G.A. (1999) Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int. J. Tuberc. Lung Dis. 3(7), 564–581.

    PubMed  CAS  Google Scholar 

  3. American Thoracic Society. (1990) Diagnostic standards and classification of tuberculosis. Am. Rev. Respir. Dis. 142(3), 725–735.

    Google Scholar 

  4. Tenover, F.C., Crawford, J.T., Heubner, R.E., Geiter, I.J., Horsburg, C.R., Good, R.C. (1993) The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31, 767–770.

    PubMed  CAS  Google Scholar 

  5. Behr, M.A., Warren, S.A., Salamon, H., et al. (1999) Transmission of M. tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353, 444–449.

    Article  PubMed  CAS  Google Scholar 

  6. Gupta, R. Espinal, M.A., Raviglione, M.C. (2004) Tuberculosis as a major global health problem in 21st century, in: Tuberculosis and Other Mycobacterial Infections (Heifets, L., ed.), Semin. Respir. Crit. Care Med. 25(3), 245–253.

    Google Scholar 

  7. World Health Organization. (March 24, 1997) TB Treatment Observer. WHO, Geneva.

    Google Scholar 

  8. Farmer, P., Bayona, J., Becerra, M., et al. (1998) The dilemma of MDR-TB in the global era. Int. J. Tuberc. Lung Dis. 2, 869–876.

    PubMed  CAS  Google Scholar 

  9. Pablos-Mendez, A., Raviglione, M.C., Laszlo, A., et al. (1998) Global surveillance for antituberculosis drugs resistance 1994–1997. N. Engl. J. Med. 338, 1641–1649.

    Article  PubMed  CAS  Google Scholar 

  10. Espinal, M.A., Laszlo, A., Simonsen, L., et al. (2001) Global trends in resistance to antituberculosis drugs. N. Engl. J. Med. 344, 1294–1303.

    Article  PubMed  CAS  Google Scholar 

  11. World Health Organization. (1998) Atituberculosis Drug Resistance in the World. The WHO/IUTLD Global Project on Antituberculosis Drug Resistance Surveillancein 1994–1997. WHO, Geneva.

    Google Scholar 

  12. World Health Organization. (2002) An Expanded DOTS Framework for Effective Tuberculosis Control. WHO/CDS/TB/2002, 297. WHO, Geneva.

    Google Scholar 

  13. World Health Organization. (2005) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO/HTM/TB/2005, 349. WHO, Geneva.

    Google Scholar 

  14. Canetti, G., Froman, S., Grosset, J., et al. (1963) Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 29, 565–578.

    PubMed  CAS  Google Scholar 

  15. Canetti, G., Fox, W., Khomenko, A., Mahler, H.T., Menon, M.K., Mitchison, D.A., Rist, M., Smelev, M.A. (1969) Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs. Bull. World. Health Organ. 41, 21–43.

    PubMed  CAS  Google Scholar 

  16. Telenti, A. (1997) Genetics of drug resistance in tuberculosis, in: Tuberculosis (Iseman, M., Huitt, G., eds.), Clin. Chest Med. 18, 55–64.

    Article  PubMed  CAS  Google Scholar 

  17. Takiff, H.E. (2000) The molecular mechanisms of drug resistance, in M. tuberculosis, in: Multi-drug Resistant Tuberculosis (Bastian, I., Portaels, F., eds.), Kluwer, Dordrecht, the Netherlands, pp.77–114.

    Google Scholar 

  18. David, H.L. (1971) Fundamentals of Drug Susceptibility Testing in Tuberculosis. HEW Publication No. 00-2165. CDC, Atlanta, GA.

    Google Scholar 

  19. Kent, P.T., Kubica, G.P. (1985) Public Health Mycobacteriology. A Guide for the Level III Laboratory. CDC, Atlanta, GA.

    Google Scholar 

  20. Heifets, L., Sanchez, T. (2003/2005) New Agar Medium for Mycobacteria (HSTB). [US Patent No. 6,579,694 B2 and 6,951,733 B2].

    Google Scholar 

  21. Heifets, L. (2000) Conventional methods for antimicrobial susceptibility testing of M. tuberculosis, in: Multidrug-Resistant Tuberculosis (Bastian, I., Portaels, F., eds.), Kluwer, Dordrecht, the Netherlands, pp. 133–143.

    Google Scholar 

  22. Madison, B.M., Siddiqi, S.H., Heifets, L., et al. (2004) Identification of a Mycobacterium tuberculosis strain with stable, low-level resistance to isoniazid. J. Clin. Microbiol. 42(3), 1294–1295.

    Article  PubMed  CAS  Google Scholar 

  23. Siddiqi, S.H., Libonati, J.P., Middlebrook, G. (1981) Evaluation of a rapid radiometric method for drug susceptibility testing of M. tuberculosis. J. Clin. Microbiol. 13, 908–912.

    PubMed  CAS  Google Scholar 

  24. Roberts, G.D., Goodman, N.L., Heifets L., et al. (1983) Evaluation of the BACTEC radiometric method for recovery mycobacteria and drug susceptibility testing of M. tuberculosis acid-fast smear-positive specimens. J. Clin. Microbiol. 18, 689–696.

    PubMed  CAS  Google Scholar 

  25. Siddiqi, S.H., Hawkins, J.E., Laszlo, A. (1985) Interlaboratory drug susceptibility testing of M. tuberculosis by radiometric and two conventional methods. J. Clin. Microbiol. 22, 919–923.

    PubMed  CAS  Google Scholar 

  26. Heifets, L.B. (1986) Rapid automated method (BACTEC system) in clinical mycobacteriology. Semin. Respir. Infect. 1, 242–249.

    PubMed  CAS  Google Scholar 

  27. Bemer, P., Bodmer, T., Munzinger, J., Perrin, M., Vincent, V., Drugeon, H. (2004) Multicenter evaluation of the MB/BacT system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 42, 1030–1034.

    Article  PubMed  CAS  Google Scholar 

  28. Tortoli, E., Mattei, R., Savarino, A., Bartolini, L., Beer, J. (2000) Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460 TB (Becton Dickinson) and MB/ BacT (Organon Teknika) systems. Diagn. Microbiol. Infect. Dis. 38, 83–86.

    Article  PubMed  CAS  Google Scholar 

  29. Heifets, L. (2002) Susceptibility testing of M. tuberculosis to pyrazinamide. J. Med. Microbiol. 51(1), 11–12.

    PubMed  Google Scholar 

  30. Pfyffer, G.E., Bonato, D.A., Ebrahimzade, A., et al. (1999) Multicenter laboratory validation of susceptibility testing of M. tuberculosis against second-line and newer antimicrobial drugs by using the radiometric Bactec-460 technique and the proportion method with solid media. J. Clin. Microbiol. 37(10), 3179–3186.

    PubMed  CAS  Google Scholar 

  31. Krüüner, A., Yates, M.D., Drobniewski, F.A. (2006) Evaluation of MGIT 960-bases antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of M. tuberculosis. J. Clin. Microbiol. 44(3), 811–818.

    Article  PubMed  CAS  Google Scholar 

  32. National Committee for Clinical Laboratory Standards. (2003) Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes. Approved Standard M24-A. NCCLS, Wayne, PA.

    Google Scholar 

  33. Mitchison, D.A. (1998) Standardisation of sensitivity tests (letter) Int. J. Tuberc. Lung Dis. 2, 69.

    PubMed  CAS  Google Scholar 

  34. Piersimoni, C., Olivieri, A., Benacchio, L., Scarparo, C. (2006) Current perspectives on drug susceptibility testing of M. tuber- culosis complex: the automated nonradiometric systems. J. Clin. Microbiol. 44(1), 20–28.

    Article  PubMed  CAS  Google Scholar 

  35. Palomino, J.C. (2005) Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur. Respir. J. 26, 339–350.

    Article  PubMed  CAS  Google Scholar 

  36. Jain, K.K. (2003) Nanodiagnostics: application of nanotechnology in molecular diagnostics. Expert Rev. Mol. Diagn. 3, 153–161.

    Article  PubMed  CAS  Google Scholar 

  37. Rattan, A., Kalia, A., Ahmad, N. (1998) Multi-drug resistant tuberculosis: molecular perspectives. Emerg. Infect. Dis. 4, 195–209.

    Article  PubMed  CAS  Google Scholar 

  38. Somoskovi, A., Parsons, L., Salfinger, M. (2001) The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2, 164–168.

    Article  PubMed  CAS  Google Scholar 

  39. Chaves, F., Alonso-Sanz, M., Rebollo, M.J., Tercero, J.C., Jiminez, M.S., Noriega, A.R. (2000) rpoB mutations as an epidemiological marker of rifampin-resistant M. tuberculosis. Int. J. Tuberc. Lung Dis. 4, 765–770.

    PubMed  CAS  Google Scholar 

  40. Garcia, L., Alonso-Sanz, M., Rebollo, M.J., Tercero, J.C., Chaves, F. (2001) Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 39, 1813–1818.

    Article  PubMed  CAS  Google Scholar 

  41. Telenti, A., Honore, N., Bernasconi, C., March, J., Ortega, A., Heym, B., et al. (1997) Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35, 719–723.

    PubMed  CAS  Google Scholar 

  42. Watterson, S.A., Wilson, S.M., Yates, M.D., Drobniewski, F.A. (1998) Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 36, 1969–1973.

    PubMed  CAS  Google Scholar 

  43. Rossau, R., Traore, H., De Beenhouwer, H., Mijs, W., Jannes, G., De Rijk, P., et al. (1997) Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41, 2093–2098.

    PubMed  CAS  Google Scholar 

  44. Somoskovi, A., Song, Q., Mester, J., Tanner, C., Hale, Y.M., Parsons, L.M., et al. (2003) Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other Mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J. Clin. Microbiol. 41, 2822–2826.

    Article  PubMed  CAS  Google Scholar 

  45. Bartfai, Z., Somoskovi, A., Kodmon, C., Szabo, N., Puskas, E., Kosztolanyi, L., et al. (2001) Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39, 3736–3739.

    Article  PubMed  CAS  Google Scholar 

  46. Johansen, I.S., Lundgren, B., Sosnovskaja, A., Thomsen, V.O. (2003) Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J. Clin. Microbiol. 41, 4454–4456.

    Article  PubMed  CAS  Google Scholar 

  47. Viveiros, M., Leandro, C., Rodrigues, L., Almeida, J., Bettencourt, R., Couto, I., et al. (2005) Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J. Clin. Microbiol. 43, 4880–4884.

    Article  PubMed  CAS  Google Scholar 

  48. El Hajj, H.H., Marras, S.A.E., Tyagi, S., Kramer, F.R., Alland, D. (2001) Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J. Clin. Microbiol. 39, 4131–4137.

    Article  PubMed  CAS  Google Scholar 

  49. Vernet, G., Jay, C., Rodriguez, M., Troesch, A. (2004) Species differentiation and antibiotic susceptibility testing with DNA microarrays. J. Appl. Microbiol. 96, 59–68.

    Article  PubMed  CAS  Google Scholar 

  50. Edwards, K.J., Metherell, L.A., Yates, M., Saunders, N.A. (2001) Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J. Clin. Microbiol. 39, 3350–3352.

    Article  PubMed  CAS  Google Scholar 

  51. Nash, K.A., Gaytan, A., Inderlied, C.B. (1997) Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and effective RNA/RNA mismatch assay. J. Infect. Dis. 176, 533–536.

    Article  PubMed  CAS  Google Scholar 

  52. Garcia de Viedma, D. (2003) Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin. Microbiol. Infect. 9, 349–359.

    Article  PubMed  CAS  Google Scholar 

  53. Davies, A.P., Billington, O.J., McHugh, T.D., Mitchison, D.A., Gillespie, S.H. (2000) Comparison of phenotypic and geno-typic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38, 3686–3688.

    PubMed  CAS  Google Scholar 

  54. Sreevatsan, S., Stockbauer, K.E., Pan, X., Kreiswirth, B.N., Moghazeh, S.L., Jacobs, W.R., Jr., et al. (1997) Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41, 1677–1681.

    PubMed  CAS  Google Scholar 

  55. Banajee, N., Bobadilla-del-Valle, M., Riska, P.F., Bardarov, S., Jr., Small, P.M., Ponce-de-Leon, A., et al. (2003) Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J. Med. Microbiol. 52, 557–561.

    Article  CAS  Google Scholar 

  56. Hazbon, M.H., Guarin, N., Ferro, B.E., Rodriguez, A.L., Labrada, L.A., Tovar, R., et al. (2003) Photographic and lumino-metric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 41, 4865–4869.

    Article  PubMed  CAS  Google Scholar 

  57. Riska, P.F., Jacobs, W.R., Jr., Bloom, B.R., McKitrick, J., Chan, J. (1997) Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J. Clin. Microbiol. 35, 3225–3231.

    PubMed  CAS  Google Scholar 

  58. Eltringham, I.J., Wilson, S.M., Drobniewski, F.A. (1999) Evaluation of a bacteriophage-based assay (Phage Amplified Biologically Assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 37, 3528–3532.

    PubMed  CAS  Google Scholar 

  59. Park, D.J., Drobniewski, F.A., Meyer, A., Wilson, S.M. (2003) Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J. Clin. Microbiol. 41, 680–688.

    Article  PubMed  CAS  Google Scholar 

  60. Pearson, R.E., Dickson, J.A., Hamilton, P.T., Little, M.C., Beyer, Jr., W.F. (1997) Mycobacteriophage Specific for the Mycobacterium tuberculosis Complex. Becton, Dickinson and Company. [US Patent No. 5,612,182]. Franklin Lakes, NJ, USA.

    Google Scholar 

  61. Redmond, W.B., Cater, J.C. (1960) A bacteroiphage specific for Mycobacterium tuberculosis, varieties hominis and bovis. Am. Rev. Respir. Dis. 82, 781–786.

    PubMed  CAS  Google Scholar 

  62. Albert, H., Muzzafar, R., Mole, R.J., Trollip, A.P. (2002) Use of the FASTPlaque test for TB diagnosis in low-income countries. Int. J. Tuberc. Lung Dis. 6, 560–561.

    Google Scholar 

  63. Albert, H., Trollip, A., Seaman, T., Mole, R.J. (2004) Simple, phage-based (FASTPlaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int. J. Tuberc. Lung Dis. 8, 1114–1149.

    PubMed  CAS  Google Scholar 

  64. Pai, M., Kalantri, S., Pascopella, L., Riley, L.W., Reingold, A.L. (2005) Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J. Infect. 51, 175–187.

    Article  PubMed  Google Scholar 

  65. Pina-Vaz, C., Costa-de-Oliveira, S., Rodrigues, A.G. (2005) Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16. J. Med. Microbiol. 54, 77–81.

    Article  PubMed  CAS  Google Scholar 

  66. Moore, A.V., Kirk, S.M., Callister, S.M., Mazurek, G.H., Schell, R.F. (1999) Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J. Clin. Microbiol. 37, 479–483.

    PubMed  CAS  Google Scholar 

  67. Cangelosi, G.A., Brabant, W.H., Britschgi, T.B., Wallis, C.K. (1996) Detection of rifampin- and ciprofloxacin-resistant Mycobacterium tuberculosis by using species-specific assays for precursor rRNA. Antimicrob. Agents Chemother. 40, 1790–1795.

    PubMed  CAS  Google Scholar 

  68. Abate, G., Aseffa, A., Selassie, A,. Goshu, S., Fekade, B., WoldeMeskal, D., et al. (2004) Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 42, 871–873.

    Article  PubMed  CAS  Google Scholar 

  69. Caviedes, L., Delgado, J., Gilman, R.H. (2002) Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 40, 1873–1874.

    Article  PubMed  CAS  Google Scholar 

  70. Collins, L., Franzblau, S.G. (1997) Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41, 1004–1009.

    PubMed  CAS  Google Scholar 

  71. Moore, D.A.J., Mendoza, D., Gilman, R.H., Evans, C.A.W., Hollm Delgado, M.G., Guerra, J., et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J. Clin. Microbiol. 42, 4432–4437.

    Article  PubMed  CAS  Google Scholar 

  72. Syre, H., Valvatne, H., Sandven, P., Grewal, H.M.S. (2006) Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures. J. Antimicrob. Chemother. l054.

    Google Scholar 

  73. Hara-Kudo, Y, Yoshino, M., Kojima, T., Ikedo, M. (2005) Loop-mediated isothermal amplification for the rapid detection of Salmonella. FEMS Microbiol. Lett. 253, 155–161.

    Article  PubMed  CAS  Google Scholar 

  74. Poon, L.L.M., Wong, B.W.Y., Ma, E.H.T., Chan, K.H., Chow, L.M.C., Abeyewickreme, W., et al. (2006) Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin. Chem. 52, 303–306.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mycobacterial Reference Laboratory, National Jewish Medical and Research Center, Denver, CO, USA

    Leonid Heifets

  2. Department of Global Health, Seattle Biomedical Research Institute, University of Washington, Seattle, WA, USA

    Gerard Cangelosi

Authors
  1. Leonid Heifets
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerard Cangelosi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Executive Vice President & Chief Medical Officer, Idenix Pharmaceuticals, Cambridge, MA, USA

    Douglas L. Mayers MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Heifets, L., Cangelosi, G. (2009). Drug Resistance Assays for Mycobacterium tuberculosis . In: Mayers, D.L. (eds) Antimicrobial Drug Resistance. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-595-8_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-595-8_35

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-594-1

  • Online ISBN: 978-1-60327-595-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation